Latest Stock Split Details
Key information about Aligos Therapeutics, Inc.'s most recent stock split
Split Date: 2024-08-19
Split Ratio: 1:25
Price Before Split: $0.57
Price After Split: $0.02
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 25.00 times fewer shares (a 1:25 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Aligos Therapeutics, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2024-08-19 | 1:25 | Yes | $0.57 | $0.02 |
About Aligos Therapeutics, Inc.
Company overview and industry information
Aligos Therapeutics, Inc. (ALGS) operates in the Biotechnology industry. The recent 1-for-25 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to Aligos Therapeutics, Inc. Summary